SCHEMBL6944977

SCHEMBL6944977

CCOc1ccc(CNC(=O)c2cc([N+](=O)[O-])ccc2N[C@H]2CC[C@@H](N)CC2)cc1OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.44
KMT2A Q03164 1/20 0.43
NPBWR1 P48145 1/20 0.42
MCHR1 Q99705 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SSTR5 P35346 1/20 0.41
LMNA P02545 4/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
AKR1C3 P42330 1/20 0.40
CCR5 P51681 1/20 0.39
RAB9A P51151 1/20 0.39
POLB P06746 2/20 0.38
HTT P42858 1/20 0.38
TBXA2R P21731 3/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
DRD3 P35462 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6944432 1.00 MAPT (0.44) MAPTKMT2ANPBWR1MCHR1NPSR1
SCHEMBL6944427 1.00 MAPT (0.44) MAPTKMT2ANPBWR1MCHR1NPSR1
SCHEMBL6938952 0.96 LMNA (0.45) MAPTKMT2ANPBWR1MCHR1NPSR1
SCHEMBL6938956 0.96 LMNA (0.45) MAPTKMT2ANPBWR1MCHR1NPSR1
SCHEMBL6938938 0.90 NPSR1 (0.48) MAPTKMT2ANPSR1L3MBTL1LMNA
SCHEMBL6938934 0.90 NPSR1 (0.48) MAPTKMT2ANPSR1L3MBTL1LMNA
SCHEMBL6942691 0.90 NPSR1 (0.48) MAPTKMT2ANPSR1L3MBTL1LMNA
SCHEMBL6940791 0.88 SSTR5 (0.46) MAPTKMT2ANPBWR1MCHR1NPSR1
SCHEMBL6939759 0.88 LMNA (0.46) MAPTKMT2ANPBWR1MCHR1NPSR1
SCHEMBL6939757 0.88 LMNA (0.46) MAPTKMT2ANPBWR1MCHR1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1080069-B1 ANTHRANILIC ACID DERIVATIVES AS INHIBITORS OF THE CGMP-PHOSPHODIESTERASE FUJISAWA PHARMACEUTICAL CO (JP) 2003-03-19 EP disclosed